NABP, FDA Collaborate to Improve Compounding Pharmacy Oversight
In 2012, many of the people who received contaminated steroid injections produced at the New England Compounding Center had already been suffering from chronic pain. The compounded drugs were supposed to provide relief. Instead, they infected these patients with fungal meningitis, killing 64 and sickening 753. The tragedy was a wakeup call for regulators, […]
Read More ›
Page 1 of 1